Tandem Diabetes Care

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNDM and other ETFs, options, and stocks.

About TNDM

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. 

CEO
John F. Sheridan
CEOJohn F. Sheridan
Employees
2,650
Employees2,650
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2006
Founded2006
Employees
2,650
Employees2,650

TNDM Key Statistics

Market cap
1.50B
Market cap1.50B
Price-Earnings ratio
-7.25
Price-Earnings ratio-7.25
Dividend yield
Dividend yield
Average volume
1.76M
Average volume1.76M
High today
$22.50
High today$22.50
Low today
$21.34
Low today$21.34
Open price
$21.58
Open price$21.58
Volume
1.80M
Volume1.80M
52 Week high
$38.28
52 Week high$38.28
52 Week low
$9.98
52 Week low$9.98

Stock Snapshot

With a market cap of 1.5B, Tandem Diabetes Care(TNDM) trades at $22.50. The stock has a price-to-earnings ratio of -7.25.

On 2025-12-15, Tandem Diabetes Care(TNDM) stock moved within a range of $21.34 to $22.50. With shares now at $22.50, the stock is trading +5.5% above its intraday low and 0.0% below the session's peak.

Trading volume for Tandem Diabetes Care(TNDM) stock has reached 1.8M, versus its average volume of 1.76M.

The stock's 52-week range extends from a low of $9.98 to a high of $38.28.

The stock's 52-week range extends from a low of $9.98 to a high of $38.28.

TNDM News

Nasdaq 4d
Don't Buy Tandem Diabetes Care Until This Big Thing Happens

Key Points Tandem Diabetes Care's top-line growth hasn't been great over the past few years. If it can successfully address challenges detrimental to revenue...

Don't Buy Tandem Diabetes Care Until This Big Thing Happens
Nasdaq 7d
Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now

Tandem Diabetes Care, Inc.’s TNDM growth is backed by its impressive range of new products. The flourishing diabetes market provides a favorable opportunity for...

Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now
Simply Wall St 7d
Did Tandem’s Insulin Pump Correction and Securities Probe Just Shift Tandem Diabetes Care's Investment Narrative?

In August 2025, Tandem Diabetes Care issued a voluntary medical device correction for select t:slim X2 insulin pumps after identifying a potential speaker-relat...

Did Tandem’s Insulin Pump Correction and Securities Probe Just Shift Tandem Diabetes Care's Investment Narrative?

Analyst ratings

64%

of 25 ratings
Buy
32%
Hold
64%
Sell
4%

People also own

Based on the portfolios of people who own TNDM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.